A critical requirement for the future of outstanding health care in the United States is the training of physician-scientists who will investigate fundamental basic science questions which ultimately relate to clinical problems. The mission of the M.D./Ph.D. program of Mayo Medical and Graduate Schools is to train a small number of gifted students in the methods, tools and disciplines of the laboratory basic scientist, while also helping them develop skills for relieving human suffering. The faculty for the Mayo MSTP will include 57 of the most highly productive, well-funded research scientists at the Mayo Clinic with demonstrated abilities for mentoring young scientists. The seamless integration of the M.D./Ph.D. program between Mayo Medical School and Mayo Graduate School parallels the complete integration of basic research and clinical investigation at Mayo. These collaborations among Ph.D. scientists and physician scientists model the future careers for M.D./Ph.D. students. The Mayo M.D./Ph.D. program enrolls approximately 6 new students each year in a medical school class o 42. M.D./Ph.D. students are selected from an annual applicant pool of about 150 of the most talented future physician scientists in the country. During their M.D./Ph.D. training they mature into highly productive basic scientists. The integrated basic science core curriculum and programmatic approach to research allows flexible access to an outstanding selection of research faculty as mentors for Mayo MSTP students. Although this is a relatively young program, 39 students have graduated and 36 are currently enrolled. Graduates are continuing on toward successful careers and continuing to make significant scientific contributions. As an NIGMS-designated MSTP the Mayo program will be able to further improve and increase its impact on the training of much-needed physician scientists prepared to apply the explosive growth in biomedical information to important clinical problems.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
1T32GM065841-01
Application #
6505396
Study Section
National Institute of General Medical Sciences Initial Review Group (BRT)
Program Officer
Shapiro, Bert I
Project Start
2003-07-01
Project End
2008-06-30
Budget Start
2003-07-01
Budget End
2004-06-30
Support Year
1
Fiscal Year
2003
Total Cost
$92,043
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Singh, Raman Deep; Hillestad, Matthew L; Livia, Christopher et al. (2018) M3RNA Drives Targeted Gene Delivery in Acute Myocardial Infarction. Tissue Eng Part A :
Wilton, Katelynn M; Matteson, Eric L; Crowson, Cynthia S (2018) Risk of Obstructive Sleep Apnea and Its Association with Cardiovascular and Noncardiac Vascular Risk in Patients with Rheumatoid Arthritis: A Population-based Study. J Rheumatol 45:45-52
Smestad, John; Erber, Luke; Chen, Yue et al. (2018) Chromatin Succinylation Correlates with Active Gene Expression and Is Perturbed by Defective TCA Cycle Metabolism. iScience 2:63-75
Cohen, Devon A; Lopez-Chiriboga, A Sebastian; Pittock, Sean J et al. (2018) Posttransplant autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm 5:e497
Wilton, Katelynn M; Billadeau, Daniel D (2018) VASP Regulates NK Cell Lytic Granule Convergence. J Immunol 201:2899-2909
Naylor, Ryan M; Wohl, Anton; Raghunathan, Aditya et al. (2018) Novel suprasellar location of desmoplastic infantile astrocytoma and ganglioglioma: a single institution's experience. J Neurosurg Pediatr 22:397-403
Jo, Hang Joon; McCairn, Kevin W; Gibson, William S et al. (2018) Global network modulation during thalamic stimulation for Tourette syndrome. Neuroimage Clin 18:502-509
Moyer, Ann M; de Andrade, Mariza; Faubion, Stephanie S et al. (2018) SLCO1B1 genetic variation and hormone therapy in menopausal women. Menopause 25:877-882
Li, Lei; Liu, Tongzheng; Li, Yunhui et al. (2018) The deubiquitinase USP9X promotes tumor cell survival and confers chemoresistance through YAP1 stabilization. Oncogene 37:2422-2431
Paradise, Brooke D; Barham, Whitney; Fernandez-Zapico, Martín E (2018) Targeting Epigenetic Aberrations in Pancreatic Cancer, a New Path to Improve Patient Outcomes? Cancers (Basel) 10:

Showing the most recent 10 out of 112 publications